PREMOD2 With Near Infrared Spectroscopy Sub-study

NCT03145142 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2021-12-13

No results posted yet for this study

Summary

Early hemodynamic effects (within 3 hours of life) of Delayed Cord Clamping compared to Umbilical Cord Milking are still unknown. Four sites experienced in the use of NIRS and who have appropriate data collection equipment in the delivery room (Alberta, Ulm, Cork and San Diego) will obtain and report the physiological changes with UCM and DCC from birth until 24 hours of life. This data will yield the largest available sample of continuously recorded heart rate, cerebral tissue oxygenation, peripheral oxygen saturation, airway pressure, and administered FiO2 to delineate the short term responses to two methods of placental transfusion. In our initial trial we demonstrated increased blood pressure from 3-15 HOL with UCM compared to DCC in premature newborns \<32 weeks, but did not show any differences in cerebral oxygenation.

Conditions

  • Hypoxia, Brain
  • Premature Birth

Interventions

PROCEDURE

Umbilical cord milking

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before it is clamped. The procedure infuses a placental transfusion of blood into the preterm infant and can be done in 15-20 seconds

PROCEDURE

Delayed Cord Clamping

At delivery, delayed cord clamping will be performed by having the delivering obstetrician delay clamping of the umbilical cord for at least 60 seconds.

Sponsors & Collaborators

  • University of Ulm

    collaborator OTHER
  • University College Cork

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • Sharp HealthCare

    lead OTHER

Principal Investigators

  • Anup C Katheria, MD · Sharp Mary Birch Hospital for Women & Newborns

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
23 Weeks
Max Age
28 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2018-09-17
Completion
2024-12-15

Countries

  • United States
  • Canada
  • Germany
  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03145142 on ClinicalTrials.gov